Skip to main content

Advertisement

Log in

Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges

  • Review Article
  • Published:
3 Biotech Aims and scope Submit manuscript

Abstract

Utility of silver metal in antimicrobial therapy is an accepted practice since ages that faded with time because of the identification of a few silver resistant strains in the contemporary era. A successive development of antibiotics soon followed. However, due to an indiscriminate and unregulated use coupled with poor legal control measures and a dearth of expertise in handling the critical episodes, the antibiotics era has already seen a steep decline in the past decades due to the evolution of multi-drug resistant ‘superbugs’ which pose a sizeable challenge to manage with. Due to limited options in the pipeline and no clear strategy in the forefront, the aspirations for novel, MDR focused drug discovery to target the ‘superbugs’ arose which once again led to the rise of AgNPs in antimicrobial research. In this review, we have focused on the green routes for the synthesis of AgNPs, the mode of microbial inhibition by AgNPs, synergistic effect of AgNPs with antibiotics and future challenges for the development of nano-silver-based therapeutics.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Abbreviations

RT:

Room temperature

AgNPs:

Silver nanoparticles

References

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Parteek Prasher.

Ethics declarations

Conflict of interest

Parteek Prasher, Manjeet Singh and Harish Mudila declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prasher, P., Singh, M. & Mudila, H. Silver nanoparticles as antimicrobial therapeutics: current perspectives and future challenges. 3 Biotech 8, 411 (2018). https://doi.org/10.1007/s13205-018-1436-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13205-018-1436-3

Keywords

Navigation